Distribution of the Patients Among the Different SCID Subgroups Before and After Haploidentical BMT
. | No. of Patients . | Alive With Donor T-Cell Engraftment at 6 Mo Post-BMT . | Alive at Last Follow-Up (median, 6 yr) . |
---|---|---|---|
Absence of T lymphocytes B+ SCID | 107 | 71 | 62 |
Absence of T and B lymphocytes B− SCID | 50 | 24 | 15 |
Adenosine deaminase deficiency | 20 | 12 | 8 |
Other types of SCID | 10 | 5 | 5 |
Reticular dysgenesis | 6 | 4 | 2 |
Total | 193 | 116 | 92 |
. | No. of Patients . | Alive With Donor T-Cell Engraftment at 6 Mo Post-BMT . | Alive at Last Follow-Up (median, 6 yr) . |
---|---|---|---|
Absence of T lymphocytes B+ SCID | 107 | 71 | 62 |
Absence of T and B lymphocytes B− SCID | 50 | 24 | 15 |
Adenosine deaminase deficiency | 20 | 12 | 8 |
Other types of SCID | 10 | 5 | 5 |
Reticular dysgenesis | 6 | 4 | 2 |
Total | 193 | 116 | 92 |